OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
The solution, aimed at businesses and public bodies, provides employees and users of public services with sovereignty over their identity, allowing them to ...
Grammy winning guitarist and composer launches a new imprint, Uniquity Music, with his new studio album, Side-Eye III+, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results